A Novel Cellular Therapy for Preterm Complications: Safety Profile of Allogeneic Cord Blood Mononuclear Cells in a Pilot Clinical Study.

Chen J, Mei Y, He L, Du Z, Xing G, Du X, Cheng L, Wei X, Zhao D, Gu Y, Li Q, Feng Z

DOI: 10.1155/sci/9979914
Published: 2026
Container: Stem cells international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/sci/9979914,
  title = {A Novel Cellular Therapy for Preterm Complications: Safety Profile of Allogeneic Cord Blood Mononuclear Cells in a Pilot Clinical Study.},
  author = {Chen J and Mei Y and He L and Du Z and Xing G and Du X and Cheng L and Wei X and Zhao D and Gu Y and Li Q and Feng Z},
  year = {2026},
  journal = {Stem cells international},
  doi = {10.1155/sci/9979914},
  url = {https://doi.org/10.1155/sci/9979914}
}

RIS

TY  - JOUR
TI  - A Novel Cellular Therapy for Preterm Complications: Safety Profile of Allogeneic Cord Blood Mononuclear Cells in a Pilot Clinical Study.
AU  - Chen J
AU  - Mei Y
AU  - He L
AU  - Du Z
AU  - Xing G
AU  - Du X
AU  - Cheng L
AU  - Wei X
AU  - Zhao D
AU  - Gu Y
AU  - Li Q
AU  - Feng Z
PY  - 2026
JO  - Stem cells international
DO  - 10.1155/sci/9979914
UR  - https://doi.org/10.1155/sci/9979914
ER  -

APA

J, C., Y, M., L, H., Z, D., G, X., X, D., L, C., X, W., D, Z., Y, G., Q, L., & Z, F. (2026). A Novel Cellular Therapy for Preterm Complications: Safety Profile of Allogeneic Cord Blood Mononuclear Cells in a Pilot Clinical Study.. Stem cells international. https://doi.org/10.1155/sci/9979914

Source records

pubmed · retrieved 2026-09-25T19:18:52.503Z